Publications by authors named "P D Stricker"

Background: Neonates with congenital anomalies frequently require perioperative allogeneic red blood cell (RBC) transfusion. Whole cord blood for autologous transfusion to neonates may provide an alternative RBC source, but whether sufficient volumes can be collected after delayed cord clamping to reduce allogeneic RBC requirements is unknown.

Study Design And Methods: Inclusion criteria were mothers delivering a viable infant >34 weeks' gestation.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of DNA methylation as a prognostic marker in prostate cancer through two cohorts with long-term follow-up data.
  • Initial analysis of a small dataset showed that higher methylation levels were linked to lethal disease, which was confirmed in a larger cohort where 97% of samples tested positive for methylation.
  • Although methylation levels correlated with certain survival outcomes, they did not provide additional prognostic value beyond existing clinical features, indicating the need for further research into their clinical applications.
View Article and Find Full Text PDF

Objectives: To prospectively compare systemic anti-tumour immune responses induced by irreversible electroporation (IRE) and robot-assisted radical prostatectomy (RARP) in patients with localised intermediate-risk prostate cancer (PCa).

Patients And Methods: Between February 2021 and June 2022, before and after treatment (at 5, 14 and 30 days) peripheral blood samples of 30 patients with localised PCa were prospectively collected. Patient inclusion criteria were: International Society of Urological Pathologists Grade 2-3, clinical cancer stage ≤T2c, prostate-specific antigen level <20 ng/mL).

View Article and Find Full Text PDF

Objective: To review the literature on salvage treatments after focal therapy (FT) for prostate cancer (PCa).

Materials And Methods: A non-systematic literature review was conducted on PubMed, Scopus, and Web of Science up to March 15, 2024, for studies that assessed salvage treatment outcomes in patients with recurrent PCa after primary FT. Original prospective and retrospective studies with more than 10 patients were included.

View Article and Find Full Text PDF